Logo image of IBTA

IBOTTA INC-CL A (IBTA) Stock Fundamental Analysis

NYSE:IBTA - US4510511060 - Common Stock

27.36 USD
+0.29 (+1.07%)
Last: 8/22/2025, 8:15:04 PM
27.36 USD
0 (0%)
After Hours: 8/22/2025, 8:15:04 PM
Fundamental Rating

5

IBTA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 99 industry peers in the Media industry. IBTA has an excellent financial health rating, but there are some minor concerns on its profitability. IBTA is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

IBTA had positive earnings in the past year.
IBTA had a positive operating cash flow in the past year.
IBTA Yearly Net Income VS EBIT VS OCF VS FCFIBTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

With an excellent Return On Assets value of 16.06%, IBTA belongs to the best of the industry, outperforming 98.98% of the companies in the same industry.
IBTA has a better Return On Equity (27.24%) than 91.84% of its industry peers.
IBTA has a Return On Invested Capital of 7.48%. This is in the better half of the industry: IBTA outperforms 79.59% of its industry peers.
Industry RankSector Rank
ROA 16.06%
ROE 27.24%
ROIC 7.48%
ROA(3y)-2.02%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IBTA Yearly ROA, ROE, ROICIBTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 50 -50 100 150

1.3 Margins

IBTA has a better Profit Margin (26.24%) than 96.94% of its industry peers.
IBTA's Operating Margin of 9.33% is fine compared to the rest of the industry. IBTA outperforms 62.24% of its industry peers.
Looking at the Gross Margin, with a value of 83.04%, IBTA belongs to the top of the industry, outperforming 95.92% of the companies in the same industry.
Industry RankSector Rank
OM 9.33%
PM (TTM) 26.24%
GM 83.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IBTA Yearly Profit, Operating, Gross MarginsIBTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 20 -20 40 60 80

More info and screens

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IBTA is destroying value.
The number of shares outstanding for IBTA has been increased compared to 1 year ago.
IBTA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IBTA Yearly Shares OutstandingIBTA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M
IBTA Yearly Total Debt VS Total AssetsIBTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 200M 400M 600M

2.2 Solvency

IBTA has an Altman-Z score of 2.91. This is not the best score and indicates that IBTA is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.91, IBTA is doing good in the industry, outperforming 79.59% of the companies in the same industry.
There is no outstanding debt for IBTA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.91
ROIC/WACC0.85
WACC8.82%
IBTA Yearly LT Debt VS Equity VS FCFIBTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 2.37 indicates that IBTA has no problem at all paying its short term obligations.
IBTA has a Current ratio of 2.37. This is amongst the best in the industry. IBTA outperforms 81.63% of its industry peers.
IBTA has a Quick Ratio of 2.37. This indicates that IBTA is financially healthy and has no problem in meeting its short term obligations.
IBTA's Quick ratio of 2.37 is amongst the best of the industry. IBTA outperforms 81.63% of its industry peers.
Industry RankSector Rank
Current Ratio 2.37
Quick Ratio 2.37
IBTA Yearly Current Assets VS Current LiabilitesIBTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 103.05% over the past year.
Looking at the last year, IBTA shows a quite strong growth in Revenue. The Revenue has grown by 14.75% in the last year.
EPS 1Y (TTM)103.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%106.06%
Revenue 1Y (TTM)14.75%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.16%

3.2 Future

The Earnings Per Share is expected to grow by 117.50% on average over the next years. This is a very strong growth
IBTA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.87% yearly.
EPS Next Y317.84%
EPS Next 2Y179.28%
EPS Next 3Y117.5%
EPS Next 5YN/A
Revenue Next Year-5.28%
Revenue Next 2Y0.87%
Revenue Next 3Y3.87%
Revenue Next 5YN/A

3.3 Evolution

IBTA Yearly Revenue VS EstimatesIBTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
IBTA Yearly EPS VS EstimatesIBTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.5 1 1.5

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 20.73 indicates a rather expensive valuation of IBTA.
Based on the Price/Earnings ratio, IBTA is valued a bit cheaper than the industry average as 68.37% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.24, IBTA is valued a bit cheaper.
The Price/Forward Earnings ratio is 18.46, which indicates a rather expensive current valuation of IBTA.
63.27% of the companies in the same industry are more expensive than IBTA, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.82, IBTA is valued a bit cheaper.
Industry RankSector Rank
PE 20.73
Fwd PE 18.46
IBTA Price Earnings VS Forward Price EarningsIBTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as IBTA.
77.55% of the companies in the same industry are more expensive than IBTA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.65
EV/EBITDA 12.06
IBTA Per share dataIBTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

IBTA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IBTA's earnings are expected to grow with 117.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.07
PEG (5Y)N/A
EPS Next 2Y179.28%
EPS Next 3Y117.5%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IBTA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IBOTTA INC-CL A

NYSE:IBTA (8/22/2025, 8:15:04 PM)

After market: 27.36 0 (0%)

27.36

+0.29 (+1.07%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)11-13 2025-11-13
Inst Owners51.88%
Inst Owner Change-18.02%
Ins Owners7.19%
Ins Owner Change-0.01%
Market Cap777.02M
Analysts76
Price Target31.04 (13.45%)
Short Float %13.24%
Short Ratio3.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)126.15%
Min EPS beat(2)-59.33%
Max EPS beat(2)311.64%
EPS beat(4)3
Avg EPS beat(4)85.34%
Min EPS beat(4)-59.33%
Max EPS beat(4)311.64%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.89%
Min Revenue beat(2)-6.83%
Max Revenue beat(2)1.04%
Revenue beat(4)2
Avg Revenue beat(4)-2.48%
Min Revenue beat(4)-6.93%
Max Revenue beat(4)2.8%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.45%
PT rev (3m)7.67%
EPS NQ rev (1m)-0.74%
EPS NQ rev (3m)1.51%
EPS NY rev (1m)0%
EPS NY rev (3m)-9.96%
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)1.53%
Revenue NY rev (1m)-0.26%
Revenue NY rev (3m)0.41%
Valuation
Industry RankSector Rank
PE 20.73
Fwd PE 18.46
P/S 2.11
P/FCF 8.65
P/OCF 7.25
P/B 2.19
P/tB 2.19
EV/EBITDA 12.06
EPS(TTM)1.32
EY4.82%
EPS(NY)1.48
Fwd EY5.42%
FCF(TTM)3.16
FCFY11.57%
OCF(TTM)3.78
OCFY13.8%
SpS12.94
BVpS12.47
TBVpS12.47
PEG (NY)0.07
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 16.06%
ROE 27.24%
ROCE 8.65%
ROIC 7.48%
ROICexc 20.31%
ROICexgc 20.31%
OM 9.33%
PM (TTM) 26.24%
GM 83.04%
FCFM 24.45%
ROA(3y)-2.02%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 200.53%
Cap/Sales 4.73%
Interest Coverage 188.53
Cash Conversion 249.53%
Profit Quality 93.17%
Current Ratio 2.37
Quick Ratio 2.37
Altman-Z 2.91
F-Score7
WACC8.82%
ROIC/WACC0.85
Cap/Depr(3y)126.83%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.09%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%106.06%
EPS Next Y317.84%
EPS Next 2Y179.28%
EPS Next 3Y117.5%
EPS Next 5YN/A
Revenue 1Y (TTM)14.75%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.16%
Revenue Next Year-5.28%
Revenue Next 2Y0.87%
Revenue Next 3Y3.87%
Revenue Next 5YN/A
EBIT growth 1Y-50.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year211.03%
EBIT Next 3Y74.92%
EBIT Next 5YN/A
FCF growth 1Y629.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y410.29%
OCF growth 3YN/A
OCF growth 5YN/A